Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Thierry L Ory
Combining Lapatinib (GW572016), a Small Molecule Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, With Therapeutic Anti-ErbB2 Antibodies Enhances Apoptosis of ErbB2-overexpressing Breast Cancer Cells
Oncogene
Cancer Research
Genetics
Molecular Biology
Related publications
Novel Peptide/Protein Delivery System Targeting erbB2-Overexpressing Breast Cancer Cells
Novel Peptide/Protein Delivery System Targeting erbB2-Overexpressing Breast Cancer Cells
A Phase II, Randomized, Multicenter Study Evaluating the Combination of Lapatinib and Vinorelbine in Women With ErbB2 Overexpressing Metastatic Breast Cancer
Breast Cancer Research and Treatment
Cancer Research
Oncology
Targeted Lapatinib Anti-Her2/ErbB2 Therapy Resistance in Breast Cancer: Opportunities to Overcome a Difficult Problem
A Holistic in Silico Approach to Develop Novel Inhibitors Targeting ErbB1 and ErbB2 Kinases
Tropical Journal of Pharmaceutical Research
Pharmacology
Pharmaceutical Science
An Insertion Mutation of ERBB2 Enhances Breast Cancer Cell Growth and Confers Resistance to Lapatinib Through AKT Signaling Pathway
Biology Open
Biochemistry
Agricultural
Genetics
Molecular Biology
Biological Sciences
ErbB2 Inhibition by Lapatinib Promotes Degradation of Mutant P53 Protein in Cancer Cells
Oncotarget
Oncology
AKT Signaling in ERBB2-amplified Breast Cancer
Pharmacology and Therapeutics
Pharmacology
Inhibition of Ezrin Causes PKCα-mediated Internalization of Erbb2/Her2 Tyrosine Kinase in Breast Cancer Cells
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
